This article and associated images are based on a poster originally authored by Adam Buckle, Julia Unsicker and Iain McWilliam and presented at ELRIG Drug Discovery 2025 in affiliation with Arrayjet ...
SAN FRANCISCO , CA, UNITED STATES, January 14, 2026 /EINPresswire.com/ — Ainnocence today announced a major milestone in artificial-intelligence driven drug ...
KYOTO & FUJISAWA, Japan--(BUSINESS WIRE)--xFOREST Therapeutics Co., Ltd. (“xFOREST”) and Axcelead Drug Discovery Partners, Inc. (“Axcelead DDP”) today announced the launch of a joint research ...
A newly finalized guidance from the US Food and Drug Administration (FDA) helps manufacturers understand how to use near-infrared (NIR)-based analyses in evaluating drug attributes. The guidance ...
A research team co-led by scientists at The Wistar Institute has combined a promising cancer therapy with a molecule that targets tumors to treat cancer more effectively. The new approach, they ...
Scientists at the Buck Institute for Research on Aging have shown that an orally administered small molecule, N-propargylglycine (N-PPG), can completely prevent the formation of calcium oxalate kidney ...
WALTHAM, Mass. & MONTREAL--(BUSINESS WIRE)--Ventus Therapeutics, a clinical-stage biopharmaceutical company advancing two Phase 2 small-molecule programs for immunological, inflammatory, and ...
Drug discovery has not yet had its “ChatGPT moment,” according to Arman Zaribafiyan, PhD, head of product, AI simulation and platforms, at SandboxAQ, in an interview with GEN. “We can’t rely only on ...
Morning Overview on MSN
Scientists found a hidden pocket on a cancer protein that drugs were never able to grip, opening a path to a new class of precise tumor blockers
Researchers have mapped a previously unseen drug-binding pocket on PKMYT1, a kinase tied to cancer cell division, using X-ray ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results